Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.38 USD | -5.11% | -3.94% | -1.21% |
May. 23 | News Highlights : Top Company News of the Day - Thursday at 5 PM ET | DJ |
May. 23 | Sector Update: Health Care Stocks Retreat Late Afternoon | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company is in debt and has limited leeway for investment
- The firm trades with high earnings multiples: 24.45 times its 2024 earnings per share.
- With an enterprise value anticipated at 4.22 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.21% | 114B | C | ||
-5.31% | 182B | C+ | ||
-5.53% | 67.76B | A | ||
+1.22% | 51.91B | B- | ||
+7.03% | 43.23B | B- | ||
+6.07% | 41.07B | B+ | ||
+21.96% | 32.07B | B | ||
+15.86% | 25B | A- | ||
-4.81% | 24.55B | B | ||
-6.68% | 24.35B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MDT Stock
- Ratings Medtronic plc